Financials

Discussions Technicals Seasonals

WESA.X fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Wesana Health Holdings, Inc. engages in the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury. It develops evidence-based formulations and protocols that empower patients to overcome neurological, psychological and mental health ailments caused by trauma. The company was founded by Daniel Carcillo, Dawn McCollough, and Chad Bronstein on October 17, 2007 and is headquartered in Chicago, IL.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

WESA.X does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company